Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise

Contraception

Volumn 87, Issue 2, 2013, Pages 212-219

  Archer, David F ^a   Stanczyk, Frank Z ^b   Rubin, Arkady ^c   Foegh, Marie ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Agile Therapeutics   (United States)

Author keywords

Ethinyl estradiol; External conditions; Levonorgestrel; Patch; Pharmacokinetic; Transdermal

Indexed keywords

AG 200 15; CONTRACEPTIVE AGENT; ESTRADIOL; LEVONORGESTREL; UNCLASSIFIED DRUG; WATER;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BREATHING RATE; CONTRACEPTION; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; EXERCISE; HEART RATE; HUMAN; HUMIDITY; LOW DRUG DOSE; SAUNA; SIDE EFFECT; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TEMPERATURE; THERMAL EXPOSURE; TREADMILL; VENOUS THROMBOEMBOLISM;

ADHESIVES; ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, COMBINED; CROSS-OVER STUDIES; EQUIPMENT FAILURE; ETHINYL ESTRADIOL; EXERCISE; FEMALE; HOT TEMPERATURE; HUMANS; HUMIDITY; IMMERSION; LEVONORGESTREL; MIDDLE AGED; TRANSDERMAL PATCH; WATER;

EID: 84872142595     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.10.009     Document Type: Article

References (16)

1. L.S. Abrams, D.M. Skee, and J. Natarajan Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise J Clin Pharmacol 41 2001 1301 1309 (Pubitemid 33104897)
2. J. Vanakoski, and T. Seppälä Heat exposure and drugs: a review of the effects of hyperthermia on pharmacokinetics Clin Pharmacokinet 34 1998 311 322 (Pubitemid 28162186)
3. A. Fujimura, M. Sasaki, K. Harada, Y. Kumagai, K. Ohashi, and A. Ebihara Influences of bathing and hot weather on the pharmacokinetics of a new transdermal clonidine, M-5041T J Clin Pharmacol 36 1996 892 896 (Pubitemid 26384478)
4. J. Vanakoski, T. Seppälä, E. Sievi, and E. Lunell Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine Clin Pharmacol Ther 60 1996 308 315 (Pubitemid 26354451)
5. T.F. Barkve, K. Langseth-Manrique, J.E. Bredesen, and K. Gjesdal Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature Am Heart J 112 1986 537 541 (Pubitemid 16046463)
6. M.A. Ashburn, L.L. Ogden, J. Zhang, G. Love, and S.V. Basta The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat J Pain 4 2003 291 297 (Pubitemid 37013019)
7. D.F. Archer, F.Z. Stanczyk, A. Rubin, and M. Foegh Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial Contraception 85 2012 595 601
8. F.Z. Stanczyk, A. Rubin, L. Flood, and M. Foegh Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel Horm Mol Biol Clin Invest 6 2011 231 240
9. D. Devineni, D. Skee, N. Vaccaro, J. Massarella, L. Janssens, and K.D. LaGuardia Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive J Clin Pharmacol 47 4 2007 497 509 (Pubitemid 46465957)
10. R.T. Burkman Transdermal hormonal contraception: benefits and risks Am J Obstet Gynecol 197 2007 134.e1 134.e6
11. J.A. Cole, H. Norman, M. Doherty, and A.M. Walker Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users Obstet Gynecol 109 Pt 1 2007 339 346 Erratum in: Obstet Gynecol 2008;111:1449 (Pubitemid 46197426)
12. Ortho Evra® prescribing information 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc Raritan, NJ
13. H. Licea-Perez, S. Wang, C.L. Bowen, and E. Yang A semi-Automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 852 2007 69 76 (Pubitemid 46839209)
14. Lybrel® prescribing information 2010 Wyeth Pharmaceuticals Inc Philadelphia, PA
15. M.W. van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174 (Pubitemid 41133355)
16. D.F. Archer, F.Z. Stanczyk, and M. Foegh Adhesiveness and pharmacokinetics of a low-dose contraceptive patch under daily external stressors-Heat, humidity, cold water, and exercise Poster presented at the American College of Obstetricians & Gynecologists 60th Annual Clinical Meeting, May 5-9 2012 San Diego, California